More on LNTH
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $105.10 |
|
|||
| Open | $102.57 | ||||
| 52 Wk High | $10.70 | ||||
| 52 Wk Low | $1.76 | ||||
| Day High | $107.81 | ||||
| Day Low | $102.57 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 1,124,303 | ||||
- Lantheus Holdings (LNTH) PT Raised to $125 at Truist Securities
- RadioMedix names former Lantheus CEO to its board of directors
- RadioMedix Appoints Brian A. Markison to Board of Directors
- Lantheus Holdings (LNTH) PT Raised to $120 at Mizuho
- Lantheus Holdings (LNTH) PT Raised to $129 at B.Riley
- Lantheus Holdings (LNTH) Reiterated at Market Outperform by Citizens on FDA CRL
- FDA rejects Lantheus drug application over manufacturing issues
- Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide)
- Form 4 Lantheus Holdings, Inc. For: May 14 Filed by: Ber Gerard
- Form 4 Lantheus Holdings, Inc. For: May 14 Filed by: Heino Mary Anne
Entities mentioned with LNTH
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Credit Suisse | View Related Stories »
- Show More...
